what is happening with compounded tirzepatide FDA Allows Compounded Tirzepatide During

Adults aged 18 or older with a BMI of 30 or higher (obesity), or a BMI between 27 and 29.9 (overweight) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol are eligible

253,255 Several other neurologically active non-hormonal medications have been found to be helpful for reducing hot flashes

GLP-1 levels increase by up to 2*x Helping you feel full faster and for longer

Finally, sirtuin 1 (SIRT1) has the potential to become a treatment strategy for T2DM

Want to be considered for a future clinical trial

Some popular options include Ozempic, Mounjaro, Wegovy, and Trulicity